Michel Cherel (Michel Chérel)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Computed Tomography

Multiple Myeloma

Hematopoietic Stem Cell

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

EJNMMI research

This page only lists publications with an associated author ORCID identifier.

Publications

Silvano Gnesin, Nicolas Chouin, Michel Cherel, Steven Mark Dunn, Niklaus Schaefer, Alain Faivre-Chauvet, John O Prior, Judith Anna Delage
From bench to bedside: 64 Cu/ 177 Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications. EJNMMI research 13 (1) (2023)
Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O Hofgaard, Bjarne Bogen, Julie Pineau, Nathalie Le Bris, Pr Raphael Tripier, Cyrille Alliot, Férid Haddad, Michel Cherel, Nicolas Chouin, Alain Faivre-Chauvet, Latifa Rbah-Vidal
Preclinical Evaluation of a 64 Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma. Pharmaceutics 15 (7) (2023)
Clémence Maingueneau, Marion Berdal, Romain Eychenne, Joëlle Gaschet, Michel Cherel, Jean-François Gestin, François Guérard
211 At and 125 I-Labeling of (Hetero)Aryliodonium Ylides: Astatine Wins Again. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (11) (2022)
Marisa Capitao, Justine Perrin, Sylvain Simon, Sébastien Gouard, Nicolas Chouin, Frank Bruchertseifer, Alfred Morgenstern, Latifa Rbah-Vidal, Michel Cherel, Emmanuel Scotet, Nathalie Labarrière, Yannick Guilloux, Joëlle Gaschet
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model. Cancers 13 (6) (2021)
Judith Anna Delage, Silvano Gnesin, John O Prior, Jacques Barbet, Patricia Le Saëc, Séverine Marionneau-Lambot, Sébastien Gouard, Michel Cherel, Mickael Bourgeois, Niklaus Schaefer, David Viertl, Julie Katrin Fierle, Steven Mark Dunn, Alain Faivre-Chauvet
Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety. Cancers 13 (23) (2021)
Romain Eychenne, Michel Cherel, Férid Haddad, François Guérard, Jean-François Gestin
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight". Pharmaceutics 13 (6) (2021)
Clement Bailly, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saëc, Séverine Marionneau-Lambot, Philippe Moreau, Cyrille Touzeau, Françoise Kraeber-Bodere, Caroline Bodet-Milin, Michel Cherel
ImmunoPET in Multiple Myeloma-What? So What? Now What? Cancers 12 (6) (2020)
Marion Berdal, Sébastien Gouard, Romain Eychenne, Séverine Marionneau-Lambot, Mikaël Croyal, Alain Faivre-Chauvet, Michel Cherel, Joëlle Gaschet, Jean-François Gestin, François Guérard
Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chemical science 12 (4) (2020)
Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, Delphine Dansette, Clement Bailly, François Guérard, Nicolas Chouin, Ferid Haddad, Cyril Alliot, Joëlle Gaschet, Romain Eychenne, Françoise Kraeber-Bodéré, Michel Cherel
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease. Cancers 12 (9) (2020)